Oscar Health, Inc. (NYSE:OSCR) saw a 16.63 percent jump last week, with investor sentiment rising due to the company’s reaffirmation of its full-year 2025 growth guidance. At the recent Wells Fargo Healthcare Conference, Oscar Health reiterated its revenue growth guidance and operating income for the year.

CEO Mark Bertolini believes the individual market is the future of healthcare. Despite a net loss of $228.49 million in the second quarter, Oscar Health is optimistic about market stabilization in 2026. The company aims to expand the individual market into a healthcare marketplace for consumers and businesses.

While OSCR shows investment potential, some AI stocks offer better returns with less downside risk. For those seeking an inexpensive AI stock benefiting from Trump tariffs, consider exploring Insider Monkey’s report on the best short-term AI stock. Check out other stock recommendations for potential growth.

Read more at Yahoo Finance: Oscar Health (OSCR) Surges 16.6% as Firm Reaffirms 2025 Growth Guidance